The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)

This study has been completed.

Study NCT00041704 Information provided by Pfizer

First Received: July 12, 2002 Last Updated: October 17, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2004
Estimated Primary Completion Date:	No date given